These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11480441)

  • 21. Declining prevalence of cystic fibrosis since the introduction of newborn screening.
    Massie J; Curnow L; Gaffney L; Carlin J; Francis I
    Arch Dis Child; 2010 Jul; 95(7):531-3. PubMed ID: 20551198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn screening: new developments in a proven field.
    Eaton RB; Comeau AM; Zytkovicz TH; Larson C
    Clin Lab Sci; 2002; 15(4):239-44. PubMed ID: 12776784
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neonatal screening for cystic fibrosis].
    Marchac V
    Soins Pediatr Pueric; 2004 Jun; (218):21-2. PubMed ID: 15327070
    [No Abstract]   [Full Text] [Related]  

  • 24. Does early detection lead to an improved prognosis in cystic fibrosis neonates?
    Chatfield S; Owen G; Ryley H; Goodchild M; Weller P
    Acta Univ Carol Med (Praha); 1990; 36(1-4):96-8. PubMed ID: 2130733
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trials in infants with cystic fibrosis detected following newborn screening.
    Stick SM
    Paediatr Respir Rev; 2008 Sep; 9(3):176-80. PubMed ID: 18694709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening showing decreasing incidence of cystic fibrosis.
    Hale JE; Parad RB; Comeau AM
    N Engl J Med; 2008 Feb; 358(9):973-4. PubMed ID: 18305279
    [No Abstract]   [Full Text] [Related]  

  • 27. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.
    Wilfond BS; Gollust SE
    J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic fibrosis in neonates and infants.
    Minasian C; McCullagh A; Bush A
    Early Hum Dev; 2005 Dec; 81(12):997-1004. PubMed ID: 16278058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neonatal screening for cystic fibrosis : towards a national implementation in Belgium in 2019].
    Boboli H; Boemer F; Mastouri M; Seghaye MC
    Rev Med Liege; 2018 Oct; 73(10):497-501. PubMed ID: 30335254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening.
    Ren CL; Fink AK; Petren K; Borowitz DS; McColley SA; Sanders DB; Rosenfeld M; Marshall BC
    Pediatrics; 2015 Jun; 135(6):e1386-92. PubMed ID: 25963008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudomonas aeruginosa cross-infection in cystic fibrosis.
    Jones AM; Webb AK; Govan JR; Hart CA; Walshaw MJ
    Lancet; 2002 Feb; 359(9305):527-8. PubMed ID: 11853828
    [No Abstract]   [Full Text] [Related]  

  • 32. Improving the care of infants identified through Cystic Fibrosis newborn screening.
    Marshall BC; Campbell PW
    J Pediatr; 2009 Dec; 155(6 Suppl):S71-2. PubMed ID: 19914444
    [No Abstract]   [Full Text] [Related]  

  • 33. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False negative cystic fibrosis newborn screen.
    Collaco JM; Panny SR; Hamosh A; Mogayzel PJ
    Clin Pediatr (Phila); 2010 Mar; 49(3):214-6. PubMed ID: 20164071
    [No Abstract]   [Full Text] [Related]  

  • 35. Edema and hypoproteinemia in infants with cystic fibrosis. The hypoalbuminemia sometimes seen is presumably secondary to malabsorption.
    Dolan TF; Rowe DS; Gibson LE
    Clin Pediatr (Phila); 1970 May; 9(5):295-7. PubMed ID: 5445070
    [No Abstract]   [Full Text] [Related]  

  • 36. Ethical issues in cystic fibrosis newborn screening: from data to public health policy.
    Wilfond B; Rothenberg LS
    Curr Opin Pulm Med; 2002 Nov; 8(6):529-34. PubMed ID: 12394162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
    Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
    J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newborn screening for cystic fibrosis.
    Wallace J; Stein Q
    S D Med; 2006 Oct; 59(10):429-31. PubMed ID: 17124920
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.